These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32886537)

  • 1. Definition of Uveitis Refractory to Treatment: A Systematic Review in the Absence of a Consensus.
    Valenzuela RA; Flores I; Pujol M; Llanos C; Carreño E; Rada G; Herbort CP; Cuitino L; Urzua CA
    Ocul Immunol Inflamm; 2022 Jan; 30(1):174-179. PubMed ID: 32886537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative.
    Dick AD; Rosenbaum JT; Al-Dhibi HA; Belfort R; Brézin AP; Chee SP; Davis JL; Ramanan AV; Sonoda KH; Carreño E; Nascimento H; Salah S; Salek S; Siak J; Steeples L;
    Ophthalmology; 2018 May; 125(5):757-773. PubMed ID: 29310963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Pharmacother; 2014 Oct; 15(15):2141-54. PubMed ID: 25226529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR-inhibiting pharmacotherapy for the treatment of non-infectious uveitis: a systematic review protocol.
    Blair J; Barry R; Murray PI; Moore DJ; Denniston AK
    Syst Rev; 2018 Jun; 7(1):83. PubMed ID: 29885659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?
    Mastrangelo G; Foeldvari I; Anton J; Simonini G
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):40. PubMed ID: 31296236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uveitis associated with juvenile idiopathic arthritis : Optimization of immunomodulatory therapy].
    Heiligenhaus A; Tappeiner C; Walscheid K; Heinz C
    Ophthalmologe; 2016 May; 113(5):391-7. PubMed ID: 27142035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of noninfectious uveitis.
    Ferreira LB; Farrall AL; Furtado JM; Smith JR
    Arq Bras Oftalmol; 2021; 84(6):610-621. PubMed ID: 34431877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review and update on the biologic treatment of adult noninfectious uveitis: part II.
    Lee K; Bajwa A; Freitas-Neto CA; Metzinger JL; Wentworth BA; Foster CS
    Expert Opin Biol Ther; 2014 Nov; 14(11):1651-66. PubMed ID: 25226284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
    Juthani VV; Clearfield E; Chuck RS
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
    Agrawal R; Testi I; Lee CS; Tsui E; Blazes M; Thorne JE; Okada AA; Smith JR; McCluskey PJ; Kempen JH; Tappeiner C; Agarwal M; Bodaghi B; Nguyen QD; Gupta V; De Smet MD; Zierhut M; Pavesio C;
    Br J Ophthalmol; 2021 May; 105(5):639-647. PubMed ID: 32586933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of chlorambucil in intractable noninfectious uveitis: the Massachusetts Eye and Ear Infirmary experience.
    Miserocchi E; Baltatzis S; Ekong A; Roque M; Foster CS
    Ophthalmology; 2002 Jan; 109(1):137-42. PubMed ID: 11772593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
    Adán A; Mesquida M; Llorenç V; Espinosa G; Molins B; Hernández MV; Pelegrín L
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging drugs for the treatment of noninfectious uveitis.
    Pleyer U; Pohlmann D; Kardeş E; Poddubnyy D; Rademacher J
    Expert Opin Emerg Drugs; 2019 Sep; 24(3):173-190. PubMed ID: 31498689
    [No Abstract]   [Full Text] [Related]  

  • 15. Side-effects of anti-inflammatory therapy in uveitis.
    Uchiyama E; Papaliodis GN; Lobo AM; Sobrin L
    Semin Ophthalmol; 2014; 29(5-6):456-67. PubMed ID: 25325874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
    Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Guerriero S; Gentileschi S; Bacherini D; Franceschini R; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2017 Jan; 36(1):191-197. PubMed ID: 27981463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New pharmacotherapy options for noninfectious posterior uveitis.
    Pleyer U; Neri P; Deuter C
    Int Ophthalmol; 2021 Jun; 41(6):2265-2281. PubMed ID: 33634341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gold standard of noninfectious uveitis: corticosteroids.
    LeHoang P
    Dev Ophthalmol; 2012; 51():7-28. PubMed ID: 22517201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveitis in juvenile idiopathic arthritis.
    Heiligenhaus A; Minden K; Föll D; Pleyer U
    Dtsch Arztebl Int; 2015 Feb; 112(6):92-100, i. PubMed ID: 25721436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
    Muselier A; Bielefeld P; Bidot S; Vinit J; Besancenot JF; Bron A
    Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.